Introduction
The molecular nature of the first characterized oncogenes (e.g. src, ras, sis and receptor tyrosine kinases) (Blume-Jensen and Hunter, 2001 ) established that aberrant cell signaling is a salient feature of oncogenesis. The discovery in 1987 that the oncogene v-Jun was a transcription factor (Bohmann et al., 1987; Vogt et al., 1987) first signaled the connection between unregulated transcription and oncogenesis (Varmus, 1987; Vogt, 2001 ). Subsequently, simple overexpression of c-Jun was also found to be oncogenic (Vogt, 2001) . Sometime later, p53, the product of a tumor suppressor gene, also proved to be a transcription factor (Kern et al., 1991; Farmer et al., 1992; Zambetti et al., 1992) . Both c-Jun and p53 can be positive-acting transcription factors. Thus, the conclusion was drawn that the molecular definition of cancer most likely connects unbalanced signaling with unbalanced gene expression. Cancerous transformation would, therefore, involve either overactive transcription of genes with oncogenic influence or loss of transcription of genes with a capacity for tumor suppression or both (reviewed in Darnell, 2002) .
This tenet underlies the explosive use of gene array analysis of the mRNA content of various malignant cell types (Brown and Botstein, 1999; Staudt, 2003) . Such gene array experiments have clearly demonstrated that the mRNA profile of malignant cells differs between different types of tumors and that the profile of tumor cells differs from that of the presumed cells of origin. However, in already established malignant cells, the responsibility of individual overactive oncogenic transcription factors or less active tumor suppressor transcription factors in creating the different mRNA profiles of cancer cells has been impossible to discern. Furthermore, the initial events in the development of a tumor, which eventually lead to the altered mRNA profile, remain unknown.
In order to study the initial stages of oncogenesis, researchers long ago turned to transformation of cultured cells often by individual oncogenes acting on already immortal cell lines. The most frequently used transformation assay involves introduction into such cultured cells of the DNA encoding an oncogene, followed by assaying the ability of recipient cells to grow in suspension in partially solidified medium ('soft agar') (Boynton et al., 1984) . The growing colonies are usually visualized only after 10-14 days. While this assay has proven invaluable in assessing the ability of particular gene products to act as oncogenes, little has been learned about the initial molecular events, in particular, initial changes caused by oncogenic transcription factors on the way to the transformed state.
We describe here an examination of changes in mRNA content in the early stages of transformation. Stably integrated oncogenes, repressed by the presence of the tetracycline derivative, doxycycline, were released (Gossen and Bujard, 1992; Freundlieb et al., 1999) , and global mRNA distributions assayed by gene array at various times thereafter. Our aim was to determine whether and how early after oncogene release a characteristic new pattern of gene expression could be observed by comparing transformed to nontransformed cells. In addition, individual mRNAs of interest were examined by RT-PCR at various times after oncogene release.
The oncogenes chosen were STAT3-C, v-Src and Ha-Ras. STAT3 is a latent transcription factor requiring tyrosine phosphorylation for activation. Such activation can be furnished through a variety of tyrosine kinases: Jak kinases associated with cytokine receptors, receptor tyrosine kinases bound by growth factors, or through Src-like, non-receptor tyrosine kinases Levy and Darnell, 2002) . Persistent and aberrant STAT3 activation has been detected in many human cancers (Turkson et al., 1998; . The human cancer cells that contain persistently active STAT3 undergo apoptosis when dominant-negative STAT3 or antagonists of STAT3 are introduced (Grandis et al., 1998; Turkson et al., 1998) , illustrating the important antiapoptotic effect of persistently activated STAT3 (Shen et al., 2001) . Furthermore, STAT3 can be converted through insertion of cysteines near the C-terminal region of the molecule into a spontaneously dimerized and transcriptionally active protein, STAT3-C, that is oncogenic and antiapoptotic in cultured cells (Bromberg et al., 1999; Shen et al., 2001) . STAT3-C transformed cells can form tumors in mice, but with less potency than v-Src transformed cells.
The oncogene v-Src, of course, has a constitutively active tyrosine kinase and is among the most extensively studied of all oncogenic proteins. In addition, all v-Src transformed cells have persistently active STAT3, which is required for Src-mediated transformation of cells (Yu et al., 1995; Bromberg et al., 1998; Turkson et al., 1998) . Additional unspecified events must occur to raise v-Src to its full transformation potential, since v-Src produces much more robust transformation of cultured cells, more aggressive transplanted tumors and protects more completely against apoptosis induction than does STAT3-C alone (Bromberg et al., 1999) .
Ras, a small GTPase, is a powerful oncogene (Joneson and Bar-Sagi, 1997; Bar-Sagi, 2001 ). So far, as has been reported, Ras does not activate STAT3 nor Src. Ras mutations give rise to overactivation of the MAP-kinase cascade by activation of Raf1, the first of the serine kinases in this cascade (Bourne et al., 1990; Traverse et al., 1993; Ayllon and Rebollo, 2000) . Of course, MAP-kinase activation also ultimately affects gene activation (Cowley et al., 1994; Treisman, 1996) through the very large family of resident nuclear transcription factors activated by serine phosphorylation, including c-Jun. Thus, we wished to compare induced mRNAs in cells transformed by two different major oncogenes, Ras and v-Src, as well as between the apparently overlapping oncogenes v-Src and STAT3-C.
Results

Inducible expression of STAT3-C, Ha-Ras and v-Src
In these studies, we have followed the effects of the oncogenes v-Src, Ha-Ras and STAT3-C on cultured mouse fibroblasts. To produce cultures that could be inducibly transformed, NIH3T3 cells were stably transfected with tetracycline repressible plasmid constructs (Tet-Off) that encoded one of three oncogenic proteins, v-Src, Ha-Ras and STAT3-C (tagged with FLAG). Clones were selected using puromycin, and expression of the oncogenic proteins was determined. In the presence of doxycycline (a tetracycline analog), expression of the transgenes was low or not detected (Figure 1a) . Expression of STAT3-C (clones S3C4 and S3C7), Ha-Ras (clones R2 and R3) or v-Src (clones S1 and S2) appeared upon removal of doxycycline from the medium. Expression of each of the proteins was detected by Western immunoblotting of whole cell extracts as Figure 1 Derepressed protein expression. NIH3T3 cells were transfected with pBPSTR1-STAT3-C, pBPSTR1-Ha-Ras or pBPSTR1-v-Src and clones were selected (S3C4, S3C7 contain STAT3-C; R2, R3 contain Ha-Ras and S1,S2 contain v-Src) (see Materials and methods). (a) Extracts were prepared from cells incubated with 100 ng/ml doxycycline (0 time) or without doxycycline for different times and samples (100 mg) were resolved on 7.5% SDS-PAGE and immunoblotted with the appropriate monoclonal antibodies: Flag (for STAT3-C Flag), Ha-Ras or vSrc. (b-d) Indicated clones of transfected cells were grown in the presence of 100 ng/ml doxycycline or doxycycline was removed for 24 h. Immunofluorescent staining was performed using the appropriate antibodies and cells were also stained with DAPI for DNA. The great majority of derepressed cells expressed the previously repressed oncogene STAT3-C, v-Src/mRNA transformation profile K Paz et al early as 3 h following removal of the antibiotic with maximal expression (10-fold or greater) after 12 h. To determine the expression of the derepressed protein in individual cells, cultures were deprived of doxycycline for a period of 24 h and protein expression was detected using immunofluorescence. In the presence of doxycycline, little or none of the FLAG-tagged STAT3 was detected in cells containing the transgene. However, following removal of doxycycline, more than 95% of the cells expressed FLAG-tagged STAT3-C (Figure 1b) . Similar results were obtained following derepression of either Ha-Ras (Figure 1c ) or v-Src (Figure 1d ). This uniform behavior suggests that cells in these clonal cell lines had stably incorporated one of the transgenes which was doxycycline repressed, and that the great majority of the derepressed cells behaved similarly.
Induction of cell transformation upon derepression of oncogenic protein
The capacity of these oncogenic proteins to induce cellular transformation was examined next. Continually repressed cells or cells derepressed by removal of doxycycline were plated in soft agar (10 5 cells in 35 mm dish). Colonies were examined after 14 days. Cells that were continued in doxycycline formed very few colonies larger than a few cells (Figure 2) , with v-Src-containing cells proving to have the most pronounced, but still very limited, growth potential in soft agar. However, colonies of 100 or more cells were obtained, with all cells expressing any one of the derepressed oncogenes. Colonies from STAT3-Cexpressing cells were smaller than those derived from Ha-Ras-expressing cells. v-Src transformed colonies were the largest of the three (and v-Src cultures S1 and S2 had more small cell clusters without derepression compared to R2, R3, S3C4 or S3C7 cells) ( Figure 2 ). Cells from transformed colonies in soft agar were recovered and grown for an additional week on plastic dishes for further analysis. During this period, cells were estimated to go through approximately 6-8 doublings.
Global comparison of mRNAs after transformation is established
The global gene expression profile of transformed and nontransformed cells was compared by gene microarray analysis. The array used (Murine genome U74Av2, Affymetrix) contained B6000 fully annotated genes and B6000 nonannotated EST sequencess.
RNA was prepared from cells growing in doxycline medium and from each transformed cell type, and subjected to Affymetrix analysis. Of 12 488 genes and ESTs, hybridization signals for 33-45% were sufficient for detection in each of the cell samples (Table 1a) , which indicate an efficient copying of the total mRNA in each sample. For the vast majority of expressed sequences, the level of mRNAs was similar throughout the experiment and similar to the parent cultures still in the presence of doxycyline (supplemental data). As demonstrated in Table 1b , a selected group of 27 mRNAs showed increased concentrations (varying from threefold to 100-fold) in all the three types of transformed cells compared to nontransformed fibroblasts. (There were other mRNAs elevated threefold or more in each of the derepressed cultures, which were not similar among all the three derepressed cultures; supplemental data.) While the degree of change from nontransformed cells was not identical for each mRNA in each culture, a consistent elevation in so many of the same mRNAs certainly defined a 'transformed fingerprint' of mRNAs. In addition to the increased mRNAs, eight additional mRNAs were found to be decreased in all the three transformed cell types. The complete list of differentially expressed mRNAs is available as supplemental data. While some of the elevated mRNAs may be connected to the required effector functions in transformation (e.g. proliferin, hepatocyte growth factor), a clear large 'cluster' of overtly transforming overexpressed genes was not apparent.
Differentially expressed genes induced early after oncogene expression
A major object of establishing the induced transformation protocol was to examine any early changes in mRNA content on the way to transformation. Therefore, the gene expression profile early after derepression Figure 2 Colony formation on soft agar. 10 5 parental NIH3T3 cells and each of the indicated clones (S3C4, S3C7, R2, R3, S1 and S2) were plated in soft-agar medium in the presence or absence of 100 ng/ml doxycycline (see Materials and methods) and grown for 14 days Derepressed cells (lacking doxycycline) from cell lines S3C4, R2, R3, S1 and S2 were recovered from soft agar (8 days), dispersed and grown for 7 days on plastic dishes (see Materials and methods). RNA was prepared and subjected to gene array hybridization from these transformed cells and from cells that had continually been in doxycycline. Between 33% and 45% of the array chips scored on mRNA as present in the various samples. The large majority (>90%) of hybridization signals were the same in the two experiments with each pair of transformed cell lines
was assayed first using microarray analysis. Total RNA was isolated from cells at the time of doxycycline removal and 3, 6, 12 and 24 h later, and prepared for array analysis. Of the potential mRNAs, 33-45% scored as present in all the three groups of cells at each time point. However, 292 genes (2.4% of the total) were differentially expressed (up or down) twofold or more in the samples where STAT3-C had been induced for 24 h compared to the noninduced doxycycline-treated samples (Table 2a) . Similarly, 246 genes (1.9% of the total) were differentially expressed twofold or more when cells were induced to express v-Src. However, only 31 mRNAs were increased twofold or more by Ha-Ras induction. (We note that the Ha-Ras induction is of wild-type protein which when overexpressed is known to be oncogenic, but much less so than mutant Ras protein.) The microarray analysis for each of the three cell lines after 3, 6 and 12 h showed even less robust changes.
In cells expressing v-Src for 24 h, 10 mRNAs were elevated threefold or more, and six 10-fold or more compared to continually repressed cells (a partial list is presented in Table 2b ). Moreover, five of these (proliferin, decorin, terascin, serum amyloid Derepressed cells (lacking doxycycline) from cell lines S3C4, R2, R3, S1 and S2 were recovered from soft agar (8 days), dispersed and grown for 7 days on plastic dishes (see Materials and methods). RNA was prepared and subjected to gene array hybridization from these transformed cells and from cells that had continually been in doxycycline. A statistical test was performed to detect the mRNAs that changed by greater than threefold between the transformed cells (15 days) and control cells (see Materials and methods). Fold change in mRNA levels is given between transformed cells and normal cells Tables 1b and 2b ). No such large changes were detected in the STAT3-C-or Ha-Ras-expressing cells. Moreover, the total list of mRNAs exhibiting twofold or greater elevation at short times showed little similarity between the v-Src and the STAT3-C derepressed cells. Although v-Src constitutively activates STAT3, it is a considerably stronger oncogene in terms of tumor induction, tumor growth rate in mice and ability to protect against apoptosis (Bromberg et al., 1999; Shen et al., 2001) . (Each derepression experiment was carried out on two cell lines, with very similar results in each experiment. The mRNAs recorded as changed were changed to similar extents in both experiments. Thus, the results were highly reproducible. Moreover, since little change was recorded at 3, 6, or 12 h, these essentially represent replicate experiments with little mRNA variation, a factor underlining the reproducibility of the assays.) RNA samples from each time point after derepression (3, 6, 12, 24 h and 15 days), which had been used in the gene array analysis, were re-examined by RT-PCR. Included in this experiment were mRNAs known to be regulated by STAT3 (SOCS3, BclX1 and CyclinD). Also, many mRNAs were detectably changed in array analysis after the 15-day period of transformation and growth. Therefore, a number of these mRNAs were tested by RT-PCR for changes in the RNA samples from cells derepressed for short times.
The RT-PCR results ( Figure 3 ) showed a number of clear mRNA changes after derepression for between 3 and 24 h not only for known target genes but also for some mRNAs that were changed in the 15-day transformed cells that were not detected by Affymetrix analysis at the early times. These included NGF, Schlafen, cytochrome p450, Lumican, and VEGF. (VEGF has been reported to be increased in v-Src transformed cells (Niu et al., 2002) .) In addition, the elevated mRNAs at early times included BclXl, Cyclin D1 and SOCS3. Several mRNAs were elevated in parallel in STAT3-C and v-Src derepressed cells, but were not equally affected by Ha-Ras derepression (e.g. NGF and BclXl). As noted earlier, overexpression of wild-type Ha-Ras is known to be a weaker oncogene than mutant protein. Finally, in addition to mRNAs that were increased, we also tested by RT-PCR two mRNAs (TP-D52 and MDR-1) that were decreased, relative to nontransformed cells, in the 15-day sample. TP-D52 was not decreased in the first 24 h by either v-Src or Ha-Ras derepression, but was greatly decreased by 15 days. STAT3-C induction abruptly decreased TP-D52 mRNA. A decrease of MDR-1 mRNA was effected by induction of all the three oncogenes only after 15 days.
Discussion
It is now commonplace to assess gene expression profiles in malignant cells for two general reasons: (1) to aid in more accurate diagnosis and to develop prognostic statements that may be of use in finding therapy, (2) as a possible guide in finding 'target genes' (i.e. genes whose transcription is increased or decreased) that may illuminate a causal link to cancer. Implicit in these searches is the belief that deregulated transcription underlies the cancerous state. For mRNAs that are elevated, this implies overactivity of some positiveacting transcription factor.
Our initial object in these experiments was to determine whether the effects on mRNA expression of a single known oncogenic, positive-acting transcription factor, STAT3-C, could be traced from the earliest time the factor became active until the cells became transformed. Secondarily, whether any such changes plausibly relate to cell transformation. Finally, to compare mRNA profiles between STAT3-Cexpressing cells and cells expressing two potent oncogenes -Src, which acts at least in part through activating STAT3, and Ha-Ras, which does not directly do so.
The global gene expression assay failed to detect extensive large-scale changes during 3, 6, 12 or 24 h after activation of these three oncogenic proteins, although several genes including that for the secreted protein proliferin was activated from 2.5-to 24-fold in each cell type. The oncogene with the most impact on early mRNA induction was v-Src, where 10 or so mRNAs were elevated threefold or more. (In an earlier experiment of a quite different design, Malek et al. found a concordance between mRNAs that were present in human tumors and in Src transformed rat cells, but they did not report directly the changes (if any) between nontransformed rat 3Y1 cells and v-Src transformed cells.) (Malek et al., 2002) In contrast with the results, after 24 h of oncogene expression in our experiments, extensive changes were detected by gene array analysis after 15 days of continued expression. Armed with the prior knowledge (Bromberg et al., 1999; Shen et al., 2001 ) of some mRNAs that should have been increased after STAT3 activation, plus knowledge of mRNAs that were increased after 15 days of expression, we returned to test by RT-PCR for the presence of a set of such mRNAs early after expression of STAT3-C, v-Src or Ha-Ras. The RT-PCR experiments did, in fact, show that a group of the mRNAs that were increased in 15 days of oncogene expression was also expressed in cells within hours of derepression. This group included Schlafen, cytochrome p450, Proliferin, Lumican and VEGF. The overlap between expression in STAT3-Cand v-Src-expressing cells was virtually complete; nine different mRNAs (including BclXl, Cyclin D1, SOCS3 and VEGF) were increased in a similar pattern, as assayed by RT-PCR in these two cases. We also rechecked the signals on microarrays for some of the mRNAs, which we showed earlier to be increased by STAT3-C expression ( (Bromberg et al., 1999) . Some were not scored as 'present' on the gene array analysis at any time (e.g. BclXl). Thus, no changes in mRNA amount could be detected for such cases. Others such as cyclin D1 were seen to be both elevated by microarray, but more robustly elevated by RT-PCR. Three conclusions were clear from the analysis at this point: (1) The gene array method is not adequate to detect some mRNAs even if they change substantially. This has been noted before for scarce mRNAs. Furthermore, the extent of change in genes that do score in array analysis is often underestimated (Naef et al., 2002 (Naef et al., , 2003 . (2) There is a definite and obvious parallel in genes affected by STAT3-C and v-Src early during transformation. (3) After the induction of the transformed state (and after B10 cell doublings), there is a similar set of increased and decreased mRNAs, evident by global array analysis (confirmed by RT-PCR) regardless of the activating oncogene.
However, the relevance of this 'transformation elevated' (or 'transformation decreased') set of mRNAs does not immediately yield insight into the nature of proteins required for transformation. For example, most members of the group of mRNAs, encoded by genes designated ontogenetically as 'cell-cycle genes', were not strongly correlated with the transformed cell phenotype. There were, however, some more highly expressed mRNAs that fell into this category (e.g. proliferin), but the list of increased mRNAs in transformed cells yielded no pattern intuitively connected to cancer.
What is the basis for the difference in such a set of mRNA changes seen in the cells after 15 days of derepression compared to 1 day? Perhaps the first suggestion might be that not all the cells in a population are 'transformed' or 'transformable', and by 15 days the transformation susceptible cells now dominate the culture. This seems unlikely. At any time, only a fraction of the cells in a transformed culture will form colonies in soft agar (Chen et al., 1977) . Those cells can be collected and grown into cultures. When the recovered cells from the resulting cultures are replated in soft agar, approximately the same fraction will form soft-agar colonies again. Thus, it seems more likely that there is simply an intrinsic ability of transformed cells to form soft-agar colonies and v-Src-expressing cells form more colonies than the STAT3-C-expressing cells. Ha-Ras-expressing cells fall in between the two extremes. However, all cells in any particular culture likely have an equal probability of forming soft-agar colonies. Thus, when we sampled global differences in mRNAs just after derepression and at 15 days after derepression, we are not likely selecting cells but the cells are undergoing changes with time.
The clear difference in mRNA expression patterns at 15 days compared to 1 day of oncogene expression most likely requires another explanation. Perhaps a more lengthy time of oncogene expression is required, during which several cell doublings occurs. This allows for the establishment of a new steady state of gene expression and thus mRNA distribution, dependent upon the initial but continuing action of the oncogenic proteins. Such a sequential 'epigenetic' effect on transcription profiles (and rates) would not be surprising, since induction of one transcription factor can lead to a cascade of gene expression that includes new synthesis of other transcription factors. Modern developmental biology is replete with such chain-like reactions that occur over several to many cell divisions (St-Johnston and Nusslein-Volhard, 1992) .
The hundreds, if not thousands, of large-scale changes seen in comparing human tumor mRNA profiles with normal cells is often accompanied by the observation on how complicated the changes in clinical cancer are. To the degree that we can believe in cell transformation in culture as a model for early tumorigenesis, we can now conclude that the mRNA changes during transformation are also very complicated. While they begin early in the course of single oncogene expression, only after prolonged oncogene expression do permanent changes become established. However, there was in our experiments a 'signature' of mRNA array changes, diagnostic of transformation, which provides a basis for further exploration of the transformed state.
Materials and methods
Materials and antibodies
pBPSTR1-STAT3-C was a gift from J Bromberg (MSKCC, New York, NY, USA). Puromycin was purchased from Sigma Chemicals Co. (St Louis, MO, USA). Tetracycline-free FCS and doxycycline were purchased from Calbiochem (La Jolla, CA, USA). RT-Superscript, Lipofectamin and Optimem were purchased from GIBCO-BRL (Grand Island, NY, USA). MGU74Av2 genechips were obtained from Affymetrix (Santa Clara, CA, USA). Low melting agar was obtained from BMA products (Rockland, ME, USA). 
Cell lines and transfection
A full-length v-Src and Ha-Ras cDNAs were introduced into BamH1 site of pBPSTR1 vector (Paulus et al., 1996) using PCR amplification. Sequence and orientation were confirmed by restriction digestion and DNA sequencing.
Mouse NIH3T3 cells were transfected with either pBPSTR1-STAT3-C, pBPSTR1-Ha-Ras or pBPSTR1-v-Src using the Lipofectamin method as described (Duzgunes and Felgner, 1993) . At 24 h post transfection, cells were transferred into a medium containing 10% FCS and supplemented with 2 mg/ml puromycin and 100 ng/ml doxycycline. Nontransfected cells were killed by puromycin and 6 days later survivor colonies were picked up and plated on gradually larger dishes for further growth. The established cell lines used in this work were S3C4 and S3C7 containing the STAT3-C cDNA, R2 and R3 containing the Ha-Ras cDNA and S1 and S2 contiaing the v-Src cDNA. Cultures were maintained on puromycin and doxycycline medium, unless otherwise indicated.
Western immunoblotting, immunofluorescence and RT-PCR
To allow protein expression (STAT3-C, Ha-Ras or v-Src), cells were deprived of doxycycline and grown in a medium containing 10% tetracycline-free FCS. For protein extraction, cells from 35 mm dish were harvested in 200 ml buffer containing 25 mM Tris-HCl, 2 mM sodium orthovanadate, 0.5 mM EDTA, 10 mM NaF, 10 mM sodium pyrophosphate, 25 mM NaCl, 1% Tx-100 and protease inhibitor cocktail 1 : 1000, pH 7.4. Cells were frozen and thawed twice and extracts collected after centrifugation at 12 000 g for 10 min, 41C and protein measured. Samples of 50 mg were mixed with 5 Â Laemmli sample buffer (Laemmli, 1970) , resolved by SDS-PAGE under reducing conditions, and transferred onto nitrocellulose membrane for Western immunoblotting with the indicated antibodies. For RT-PCR, cells were collected and RNA was extracted using the RNeasy kit (Qiagen). For each reaction, 1 mg RNA was subjected to reverse transcription using RT-SuperScript, then amplified by 22 cycles of PCR. For immunofluorescence, cells were grown on 18 mm 2 sterile micro-cover glass. Cells attached to the glass were fixed by incubating with 3% paraformaldehyde (in PBS) at RT. At 30 min, cells were transferred to a solution containing 0.1% Triton X-100 and 3% paraformaldehyde (in PBS) for 2 min, then washed five times with PBS. Fixed cells were incubated with the indicated monoclonal antibodies for 1 h at room temperature, washed and further incubated with FITC-labeled goat anti-mouse (diluted 1 : 40) for 1 h, as previously described (Geiger et al., 1979) .
Colony growth in soft agar
Soft-agar assay was performed as previously described (Bromberg et al., 1998) . Essentially, growth in soft agar was determined in 35 mm diameter dishes prepared with a lower layer of 0.7% low melting agar solution in DMEM with 10% FCS containing 2 mg/ml of puromycin (growth medium) with or without 100 ng/ml doxycycline. Then a second layer of 0.35% agar solution in the same medium was used to resuspend 10 5 cells. Following solidification, soft-agar layers were covered by liquid growth medium, with or without 100 ng/ml doxycycline, that was changed every second day. Colonies were scored 10-14 days after preparation.
Oligonucleotide microarray analysis
Cells were plated and grown to 90% confluence on a 150 mm dish in medium supplemented with 100 ng/ml doxycycline. Cells were deprived of doxycycline and grown for 3, 6, 12 and 24 h in tetracycline-free medium containing 10% FCS. Cells were collected and RNA was extracted using the RNeasy kit (Qiagen). cDNA synthesis, biotin-labeled cRNA generation, hybridization, washing and staining of Affymetrix Genechip MG74Av2 probe arrays were carried out according to the Affymetrix technical manual in an Affymetrix hybridization oven and fluidics station. The arrays were scanned using a Hewlett-Packard confocal laser scanner and visualized using Affymetrix MAS 5.0 software (Affymetrix).
Differentially expressed genes
For each cell line, the list of expressed mRNAs at zero time was compared to those at intervals after removal of doxycyline. mRNAs that exhibited the greatest differences between the beginning and end were noted using a variant of the standard ttest: (t ¼ (mean(1)Àmean(2)/sqrt(var(1) þ var(2))) (the difference in means divided by the combined standard deviation). To estimate the variance, a constant was added to the variance: (t1 ¼ (mean(1)Àmean(2))/sqrt(var(1) þ var(2) þ sigma)) (Tusher et al., 2001) . To adjust to the noise/error in microarrays, the score use was: (t2 ¼ (mean(1)Àmean(2))/sqrt(var(1) þ sigma (mean(1)) þ var(2) þ sigma(mean(2))) (Baldi and Long, 2001) .
